Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ophthalmology (30) 30
science & technology (28) 28
life sciences & biomedicine (25) 25
humans (24) 24
male (19) 19
aged (16) 16
female (15) 15
middle aged (13) 13
aged, 80 and over (11) 11
bevacizumab (10) 10
biological and medical sciences (10) 10
fluorescein angiography (10) 10
genetic structures (8) 8
intravitreal injections (8) 8
medical sciences (8) 8
abridged index medicus (7) 7
adult (7) 7
antibodies, monoclonal, humanized (7) 7
clinical trials (7) 7
research (7) 7
vascular endothelial growth factor a - antagonists & inhibitors (7) 7
visual acuity (7) 7
antibodies, monoclonal - adverse effects (6) 6
diabetic retinopathy (6) 6
eye diseases (6) 6
injections (6) 6
online first (6) 6
original investigation (6) 6
ranibizumab (6) 6
retina (6) 6
retrospective studies (6) 6
tomography, optical coherence (6) 6
vascular endothelial growth factor (6) 6
vitreous body (6) 6
angiogenesis inhibitors - therapeutic use (5) 5
diabetes mellitus (5) 5
eye (5) 5
macular degeneration (5) 5
macular edema - drug therapy (5) 5
prospective studies (5) 5
analysis (4) 4
angiogenesis inhibitors - adverse effects (4) 4
antibodies, monoclonal - therapeutic use (4) 4
choroid - blood supply (4) 4
diabetes (4) 4
diabetic retinopathy - drug therapy (4) 4
drug therapy (4) 4
edema (4) 4
macular degeneration - complications (4) 4
macular degeneration - drug therapy (4) 4
macular edema - etiology (4) 4
microscopy, electron (4) 4
retinopathy (4) 4
sense organs (4) 4
vitrectomy (4) 4
acuity (3) 3
age-related macular degeneration (3) 3
angiogenesis inhibitors - administration & dosage (3) 3
animals (3) 3
antibodies, monoclonal - administration & dosage (3) 3
chemistry (3) 3
choroidal neovascularization - drug therapy (3) 3
consulting services (3) 3
miscellaneous (3) 3
neovascularization, pathologic - surgery (3) 3
patients (3) 3
physical sciences (3) 3
retina - pathology (3) 3
retinal vein occlusion - complications (3) 3
surgery (3) 3
treatment outcome (3) 3
visual acuity - physiology (3) 3
angiogenesis inhibitors (2) 2
angiogenesis inhibitors - pharmacokinetics (2) 2
anti-vegf (2) 2
bevacizumab - administration & dosage (2) 2
bruch membrane - surgery (2) 2
bruch membrane - ultrastructure (2) 2
bruch's membrane (2) 2
care and treatment (2) 2
cats (2) 2
cell division (2) 2
chemistry, multidisciplinary (2) 2
chemistry, physical (2) 2
choriocapillaris (2) 2
choroidal neovascularization - etiology (2) 2
cohort studies (2) 2
comparative analysis (2) 2
data processing (2) 2
debridement (2) 2
diabetic retinopathy - diagnosis (2) 2
diabetic retinopathy - physiopathology (2) 2
diagnostic techniques, ophthalmological (2) 2
disease progression (2) 2
dose-response relationship, drug (2) 2
drug therapy, combination (2) 2
endophthalmitis - diagnosis (2) 2
enzyme-linked immunosorbent assay (2) 2
follow-up studies (2) 2
fundamental and applied biological sciences. psychology (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD
by Avery, Robert L and Castellarin, Alessandro A and Steinle, Nathan C and Dhoot, Dilsher S and Pieramici, Dante Joseph and See, Robert and Couvillion, Stephen and Nasir, Ma'an A and Rabena, Melvin D and Le, Kha and Maia, Mauricio and Visich, Jennifer E
British journal of ophthalmology, ISSN 0007-1161, 12/2014, Volume 98, Issue 12, pp. 1636 - 1641
Life Sciences & Biomedicine | Ophthalmology | Science & Technology | Prospective Studies | Enzyme-Linked Immunosorbent Assay | Intravitreal Injections | Humans | Vascular Endothelial Growth Factor A - blood | Half-Life | Biological Availability | Male | Angiogenesis Inhibitors - pharmacokinetics | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Bevacizumab | Tissue Distribution | Vitreous Body - metabolism | Wet Macular Degeneration - metabolism | Antibodies, Monoclonal, Humanized - pharmacokinetics | Receptors, Vascular Endothelial Growth Factor - pharmacokinetics | Recombinant Fusion Proteins - pharmacokinetics | Ranibizumab | Female | Aged | Research | Pharmacokinetics | Vascular endothelial growth factor | Analysis | Macular degeneration | Studies | Oncology | Diabetes | Drug dosages | Molecular weight | Index Medicus | Retina | 1506 | Clinical Science
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab
by Bressler, Susan B and Liu, Danni and Glassman, Adam R and Blodi, Barbara A and Castellarin, Alessandro A and Jampol, Lee M and Kaufman, Paul L and Melia, Michele and Singh, Harinderjit and Wells, John A and Diabetic Retinopathy Clinical Res and Diabetic Retinopathy Clinical Research Network and for the Diabetic Retinopathy Clinical Research Network
JAMA ophthalmology, ISSN 2168-6165, 06/2017, Volume 135, Issue 6, pp. 558 - 568
Life Sciences & Biomedicine | Ophthalmology | Science & Technology | Severity of Illness Index | Diabetic Retinopathy - drug therapy | Bevacizumab - administration & dosage | Follow-Up Studies | Intravitreal Injections | Humans | Treatment Outcome | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Visual Acuity | Disease Progression | Receptors, Vascular Endothelial Growth Factor - administration & dosage | Diabetic Retinopathy - physiopathology | Dose-Response Relationship, Drug | Diabetic Retinopathy - diagnosis | Angiogenesis Inhibitors - administration & dosage | Time Factors | Ranibizumab - administration & dosage | Retrospective Studies | Retina - pathology | Recombinant Fusion Proteins - administration & dosage | Drug therapy | Diabetic retinopathy | Index Medicus | Abridged Index Medicus | Online First | Original Investigation | Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration
by Avery, Robert L and Pieramici, Dante J and Rabena, Melvin D and Castellarin, Alessandro A and Nasir, Ma’an A and Giust, Matthew J
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2006, Volume 113, Issue 3, pp. 363 - 372.e5
Biological and medical sciences | Miscellaneous | Medical sciences | Ophthalmology | Retina - drug effects | Choroidal Neovascularization - diagnosis | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Choroidal Neovascularization - etiology | Male | Retinal Detachment - drug therapy | Macular Degeneration - diagnosis | Macular Degeneration - drug therapy | Bevacizumab | Antibodies, Monoclonal, Humanized | Choroidal Neovascularization - drug therapy | Retinal Detachment - diagnosis | Aged, 80 and over | Vitreous Body | Female | Retrospective Studies | Antibodies, Monoclonal - immunology | Fluorescein Angiography | Macular Degeneration - physiopathology | Tomography, Optical Coherence | Fovea Centralis | Macular Degeneration - complications | Vascular Endothelial Growth Factor A - immunology | Visual Acuity | Choroidal Neovascularization - physiopathology | Pigment Epithelium of Eye | Injections | Antibodies, Monoclonal - administration & dosage | Papilledema - diagnosis | Aged | Retina - pathology | Papilledema - drug therapy | Macular degeneration | Physiological aspects | Eye diseases | Angiogenesis inhibitors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Stable Fe nanomagnets encapsulated inside vertically-aligned carbon nanotubes
by Bondino, Federica and Magnano, Elena and Ciancio, Regina and Castellarin Cudia, Carla and Barla, Alessandro and Carlino, Elvio and Yakhou-Harris, Flora and Rupesinghe, Nalin and Cepek, Cinzia
Physical chemistry chemical physics : PCCP, ISSN 1463-9076, 12/2017, Volume 19, Issue 47, pp. 3279 - 3285
Physical Sciences | Chemistry | Physics, Atomic, Molecular & Chemical | Chemistry, Physical | Physics | Science & Technology | Encapsulation | Nanotubes | Coercivity | Soft x rays | Carbon nanotubes | Iron | Electron microscopy | Substrates | Nanoparticles | Surface stability | BCC metals | Remanence | Magnetic properties
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy
by Avery, Robert L and Pearlman, Joel and Pieramici, Dante J and Rabena, Melvin D and Castellarin, Alessandro A and Nasir, Ma’an A and Giust, Matthew J and Wendel, Robert and Patel, Arun
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2006, Volume 113, Issue 10, pp. 1695 - 1705.e6
Miscellaneous | Diabetes. Impaired glucose tolerance | Retinopathies | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Medical sciences | Ophthalmology | Endocrine pancreas. Apud cells (diseases) | Diabetic Retinopathy - drug therapy | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Capillary Permeability - drug effects | Antibodies, Monoclonal - therapeutic use | Male | Bevacizumab | Antibodies, Monoclonal, Humanized | Diabetic Retinopathy - diagnosis | Angiogenesis Inhibitors - administration & dosage | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Vitreous Body | Adult | Female | Retrospective Studies | Angiogenesis Inhibitors - adverse effects | Fluorescein Angiography | Iris - blood supply | Retinal Neovascularization - diagnosis | Neovascularization, Pathologic - diagnosis | Tomography, Optical Coherence | Vascular Endothelial Growth Factor A - immunology | Visual Acuity | Injections | Antibodies, Monoclonal - administration & dosage | Neovascularization, Pathologic - drug therapy | Aged | Retinal Neovascularization - drug therapy | Diabetic retinopathy | Care and treatment | Angiogenesis inhibitors | Neovascularization | Consulting services | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Incidence of Choroidal Neovascularization in the Fellow Eye in the Comparison of Age-related Macular Degeneration Treatments Trials
by Maguire, Maureen G., PhD and Daniel, Ebenezer, MBBS, PhD and Shah, Ankoor R., MD and Grunwald, Juan E., MD and Hagstrom, Stephanie A., PhD and Avery, Robert L., MD and Huang, Jiayan, MS and Martin, Revell W., BA and Roth, Daniel B., MD and Castellarin, Alessandro A., MD and Bakri, Sophie J., MD and Fine, Stuart L., MD and Martin, Daniel F., MD and Comparison of Age-Related Macular Degeneration Treatments Trials (CATT Research Group) and Comparison Age-Related Macular
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2013, Volume 120, Issue 10, pp. 2035 - 2041
Ophthalmology | Life Sciences & Biomedicine | Science & Technology | Choroidal Neovascularization - epidemiology | Intravitreal Injections | Humans | Middle Aged | Male | Macular Degeneration - drug therapy | Bevacizumab | Incidence | Dose-Response Relationship, Drug | Choroidal Neovascularization - drug therapy | Choroidal Neovascularization - pathology | Ranibizumab | Serine Endopeptidases - genetics | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Female | Complement C3 - genetics | Genetic Predisposition to Disease | Antibodies, Monoclonal, Humanized - therapeutic use | Macular Degeneration - complications | High-Temperature Requirement A Serine Peptidase 1 | Genotype | Proteins - genetics | Macular Degeneration - genetics | Aged | Polymorphism, Single Nucleotide | Complement Factor H - genetics | Choroidal Neovascularization - genetics | Cohort Studies | Macular degeneration | Clinical trials | Physiological aspects | Neovascularization | Comparative analysis | Drug therapy | Consulting services | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Systemic pharmacokinetics and pharmacodynamics of intravitreal aflibercept, bevacizumab, and ranibizumab
by Avery, Robert L and Castellarin, Alessandro A and Steinle, Nathan C and Dhoot, Dilsher S and Pieramici, Dante J and See, Robert and Couvillion, Stephen and Nasir, Ma'An A and Rabena, Melvin D and Maia, Mauricio and Van Everen, Sherri and Le, Kha and Hanley, William D
Retina (Philadelphia, Pa.), ISSN 0275-004X, 10/2017, Volume 37, Issue 10, pp. 1847 - 1858
anti-VEGF | pharmacokinetics | retinal vein occlusion | age-related macular degeneration | diabetic macular edema | Life Sciences & Biomedicine | Ophthalmology | Science & Technology | Diabetic Retinopathy - drug therapy | Prospective Studies | Follow-Up Studies | Intravitreal Injections | Ranibizumab - pharmacokinetics | Humans | Middle Aged | Male | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Diabetic Retinopathy - complications | Macular Edema - etiology | Angiogenesis Inhibitors - administration & dosage | Female | Recombinant Fusion Proteins - administration & dosage | Bevacizumab - administration & dosage | Enzyme-Linked Immunosorbent Assay | Vascular Endothelial Growth Factor A - blood | Bevacizumab - pharmacokinetics | Angiogenesis Inhibitors - pharmacokinetics | Macular Edema - blood | Receptors, Vascular Endothelial Growth Factor - administration & dosage | Wet Macular Degeneration - diagnosis | Diabetic Retinopathy - blood | Wet Macular Degeneration - drug therapy | Recombinant Fusion Proteins - pharmacokinetics | Macular Edema - drug therapy | Wet Macular Degeneration - blood | Ranibizumab - administration & dosage | Aged | Drug therapy | Retinal diseases | Index Medicus | Original Study
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Ranibizumab for the Treatment of Macular Edema Associated with Perfused Central Retinal Vein Occlusions
by Pieramici, Dante J., MD and Rabena, Melvin, BS and Castellarin, Alessandro A., MD and Nasir, Ma'an, MD and See, Robert, MD and Norton, Tamara, MPH and Sanchez, Andres and Risard, Sarah and Avery, Robert L., MD
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2008, Volume 115, Issue 10, pp. e47 - e54
Ophthalmology | Prospective Studies | Retinal Vein Occlusion - diagnosis | Tomography, Optical Coherence | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Treatment Outcome | Visual Acuity | Retinal Vein Occlusion - complications | Antibodies, Monoclonal, Humanized | Macular Edema - etiology | Injections | Pilot Projects | Antibodies, Monoclonal - administration & dosage | Macular Edema - diagnosis | Macular Edema - drug therapy | Ranibizumab | Aged, 80 and over | Vitreous Body | Adult | Female | Aged | Fluorescein Angiography | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion
by Rabena, Melvin D and Pieramici, Dante J and Castellarin, Alessandro A and Nasir, Ma'an A and Avery, Robert L
Retina (Philadelphia, Pa.), ISSN 0275-004X, 04/2007, Volume 27, Issue 4, pp. 419 - 425
Intravitreal | Macular edema | Branch retinal vein occlusion | Avastin | Bevacizumab | Tomography, Optical Coherence | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Male | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Visual Acuity | Retinal Vein Occlusion - complications | Antibodies, Monoclonal, Humanized | Macular Edema - etiology | Injections | Retinal Vein Occlusion - drug therapy | Macular Edema - drug therapy | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Vitreous Body | Adult | Female | Aged | Retrospective Studies | Fluorescein Angiography | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text A systems-oriented analysis of the grapevine R2R3-MYB transcription factor family uncovers new insights into the regulation of stilbene accumulation
by Wong, Darren Chern Jan and Schlechter, Rudolf and Vannozzi, Alessandro and Höll, Janine and Hmmam, Ibrahim and Bogs, Jochen and Tornielli, Giovanni Battista and Castellarin, Simone Diego and Matus, José Tomás
DNA research, ISSN 1340-2838, 2016, Volume 23, Issue 5, pp. 451 - 466
Ripening | Wine | Cell wall | Stress | Radiation | Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | Index Medicus | stress | cell wall | Full Papers | ripening | radiation | wine
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Endophthalmitis After Anti-VEGF Injections
by Klein, Kathryn S., MD, MPH and Walsh, Mark K., MD, PhD and Hassan, Tarek S., MD and Halperin, Lawrence S., MD and Castellarin, Alessandro A., MD and Roth, Daniel, MD and Driscoll, Sarah, BS and Prenner, Jonathan L., MD
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2009, Volume 116, Issue 6, pp. 1225 - 1225.e1
Ophthalmology | Life Sciences & Biomedicine | Science & Technology | Humans | Risk Factors | Antibodies, Monoclonal - adverse effects | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Aptamers, Nucleotide - adverse effects | Endophthalmitis - etiology | Macular Degeneration - drug therapy | Bevacizumab | Anti-Bacterial Agents - therapeutic use | Antibodies, Monoclonal, Humanized | Injections | Ranibizumab | Vitreous Body | Endophthalmitis - diagnosis | Drug Therapy, Combination | Angiogenesis Inhibitors - adverse effects | Cohort Studies | Endophthalmitis - drug therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Trapping of Charged Gold Adatoms by Dimethyl Sulfoxide on a Gold Surface
by Feng, Zhijing and Velari, Simone and Cossaro, Albano and Castellarin-Cudia, Carla and Verdini, Alberto and Vesselli, Erik and Dri, Carlo and Peressi, Maria and De Vita, Alessandro and Comelli, Giovanni
ACS nano, ISSN 1936-0851, 09/2015, Volume 9, Issue 9, pp. 8697 - 8709
gold | adatom | dimethyl sulfoxide | DMSO | photoemission spectroscopy | density functional theory | scanning tunneling microscopy | Physical Sciences | Chemistry | Materials Science | Nanoscience & Nanotechnology | Technology | Materials Science, Multidisciplinary | Science & Technology - Other Topics | Chemistry, Multidisciplinary | Chemistry, Physical | Science & Technology | Terminations | Gold | Scanning tunneling microscopy | Charging | Mathematical analysis | Dimethyl sulfoxide | Nanostructure | Photoelectron spectroscopy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights